Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study

References

• Alam T, Khan S, Gaba B, et al. (2018). Adaptation of quality by design-based development of isradipine nanostructured-lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate. J Pharm Sci 107:2914–26.
   PubMed Web of Science ®Google Scholar
• Almeida H, Lobão P, Frigerio C, et al. (2017). Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen. Pharm Dev Technol 22:336–49.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab MM, Mostafa DM, et al. (2020). Development of folic acid-loaded nanostructured lipid carriers for topical delivery: preparation, characterisation and ex vivo investigation. J Microencapsul 37:366–83.
   PubMed Web of Science ®Google Scholar
• Barry Z, Park B, Corson TW. (2020). Pharmacological potential of small molecules for treating corneal neovascularization. Molecules 25:3468.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Solinis MA, Rodriguez-Gascon A, et al. (2016). Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine 12:143–61.
   PubMed Web of Science ®Google Scholar
• Bhalerao H, Koteshwara KB, Chandran S. (2019). Levofloxacin hemihydrate in situ gelling ophthalmic solution: formulation optimization and in vitro and in vivo evaluation. AAPS Pharm SciTech 20:272.
   PubMed Web of Science ®Google Scholar
• Bondì ML, Botto C, Amore E, et al. (2015). Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells. Int J Pharm 493:75–85.
   PubMed Web of Science ®Google Scholar
• Chen H, Gao J, Wang F, et al. (2007). Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv 14:201–8.
   PubMed Web of Science ®Google Scholar
• Chen CC, Tsai TH, Huang ZR, et al. (2010). Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 74:474–82.
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329:166–72.
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrín M, Sáez V, et al. (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28:1553–64.
   PubMed Web of Science ®Google Scholar
• Elmowafy M, Ibrahim HM, Ahmed MA, et al. (2017). Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. Drug Deliv 24:932–41.
   PubMed Web of Science ®Google Scholar
• Farghaly DA, Aboelwafa AA, Hamza MY, et al. (2018). Microemulsion for topical delivery of fenoprofen calcium: in vitro and in vivo evaluation. J Liposome Res 28:126–36.
   PubMed Web of Science ®Google Scholar
• Gönüllü Ü, Üner M, Yener G, et al. (2015). Formulation and characterization of solid lipidnanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Acta Pharmaceutica 65:1–13.
   PubMed Web of Science ®Google Scholar
• González-Fernández FM, Bianchera A, Gasco P, et al. (2021). Lipid-based nanocarriers for ophthalmic administration: towards experimental design implementation. Pharmaceutics 13:447.
   PubMed Web of Science ®Google Scholar
• Han KY, Chang JH, Lee H, et al. (2016). Proangiogenic interactions of vascular endothelial MMP14 with VEGF receptor 1 in VEGFA-mediated corneal angiogenesis. Invest Ophthalmol Vis Sci 57:3313–22.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Chang HM, Lin TC, et al. (2015). Corneal neovascularization and contemporary antiangiogenic therapeutics. J Chin Med Assoc 78:323–30.
   PubMed Web of Science ®Google Scholar
• Irani YD, Scotney PD, Klebe S, et al. (2017). An anti-VEGF-B antibody fragment induces regression of pre-existing blood vessels in the rat cornea. Invest Ophthalmol Vis Sci 58:3404–13.
   PubMed Web of Science ®Google Scholar
• Jain K, Sood S, Gowthamarajan K. (2015). Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug Deliv 22:940–54.
   PubMed Web of Science ®Google Scholar
• Jain N, Verma A, Jain N. (2020). Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv 27:888–99.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Alshamsan A, Aljuffali IA, et al. (2016). Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv 23:896–907.
   PubMed Web of Science ®Google Scholar
• Kaur N, Sharma K, Bedi N. (2018). Topical nanostructured lipid carrier based hydrogel of mometasone furoate for the treatment of psoriasis. Pharm Nanotechnol 6:133–43.
   PubMedGoogle Scholar
• Kelidari HR, Saeedi M, Akbari J, et al. (2017). Development and optimisation of spironolactone nanoparticles for enhanced dissolution rates and stability. AAPS PharmSciTech 18:1469–74.
   PubMed Web of Science ®Google Scholar
• Kernt M, Staehler M, Stief C, et al. (2008). Resolution of macular oedema in occult choroidal neovascularization under oral sorafenib treatment. Acta Ophthalmol 86:456–8.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Jain A, Srivastava A, et al. (2020). Systematic development and characterization of curcumin-loaded nanogel for topical application. Drug Dev Ind Pharm 46:1443–57.
   PubMed Web of Science ®Google Scholar
• Khan S, Baboota S, Ali J, et al. (2016). Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Drug Dev Ind Pharm 42:209–20.
   PubMed Web of Science ®Google Scholar
• Khan S, Shaharyar M, Fazil M, et al. (2016). Tacrolimus-loaded nanostructured lipid carriers for oral delivery Optimization of production and characterization. Eur J Pharm Biopharm 108:277–88.
   PubMed Web of Science ®Google Scholar
• Khezri K, Saeedi M, Morteza-Semnani K, et al. (2021). A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier. Artif Cells Nanomed Biotechnol 49:38–47.
   PubMed Web of Science ®Google Scholar
• Kovács A, Berkó S, Csányi E, et al. (2017). Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the quality by design method. Eur J Pharm Sci 99:246–57.
   PubMed Web of Science ®Google Scholar
• Kumar R, Crouthamel MC, Rominger DH, et al. (2009). Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors. Br J Cancer 101:1717–23.
   PubMed Web of Science ®Google Scholar
• Kumari S, Dandamudi M, Rani S, et al. (2021). Dexamethasone-loaded nanostructured lipid carriers for the treatment of dry eye disease. Pharmaceutics 13:905.
   PubMed Web of Science ®Google Scholar
• Lakhani P, Patil A, Taskar P, et al. (2018). Curcumin-loaded nanostructured lipid carriers for ocular drug delivery: design optimization and characterization. J Drug Deliv Sci Technol 47:159–66.
   PubMed Web of Science ®Google Scholar
• Lee P, Wang CC, Adamis AP. (1998). Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245–69.
   PubMed Web of Science ®Google Scholar
• Li J, Guo X, Liu Z, et al. (2014). Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Drug Dev Ind Pharm 40:980–7.
   PubMed Web of Science ®Google Scholar
• Li J, Li Z, Liang Z, et al. (2018). Fabrication of a drug delivery system that enhances antifungal drug corneal penetration. Drug Deliv 25:938–49.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Z, Zeng W, et al. (2014). Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci 62:115–23.
   PubMed Web of Science ®Google Scholar
• Li Z, Li J, Zhu L, et al. (2016a). Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats. Int J Nanomed 11:6135–48.
   PubMed Web of Science ®Google Scholar
• Li J, Liu D, Tan G, et al. (2016b). A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Carbohydr Polym 146:435–44.
   PubMed Web of Science ®Google Scholar
• Li H, Pan T, Cui Y, et al. (2016c). Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique. Int J Nanomed 11:3777–88.
   PubMed Web of Science ®Google Scholar
• Li Q, Yang X, Zhang P, et al. (2021). Dasatinib loaded nanostructured lipid carriers for effective treatment of corneal neovascularization. Biomater Sci 9:2571–83.
   PubMed Web of Science ®Google Scholar
• Lin L, Asghar S, Huang L, et al. (2021). Preparation and evaluation of oral self-microemulsifying drug delivery system of chlorophyll. Drug Dev Ind Pharm 47:857–66.
   PubMed Web of Science ®Google Scholar
• Liu D, Li J, Cheng B, et al. (2017). Ex vivo and in vivo evaluation of the effect of coating a coumarin-6-labeled nanostructured lipid carrier with chitosan-n-acetylcysteine on rabbit ocular distribution. Mol Pharm 14:2639–48.
   PubMed Web of Science ®Google Scholar
• Liu YC, Lin MT, Ng AHC, et al. (2020). Nanotechnology for the treatment of allergic conjunctival diseases. Pharmaceuticals 13:351.
   Web of Science ®Google Scholar
• Liu J, Wang Q, Omari-Siaw E, et al. (2020). Enhanced oral bioavailability of Bisdemethoxycurcumin-loaded self-microemulsifying drug delivery system: formulation design, in vitro and in vivo evaluation. Int J Pharm 590:119887.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang L, Zhao Y, et al. (2014). Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm 476:169–77.
   PubMed Web of Science ®Google Scholar
• Luo X, Li S, Xie Y, et al. (2013). Pharmacokinetic studies of a novel multikinase inhibitor for treating cancer by HPLC-UV. J Chromatogr Sci 51:17–20.
   PubMed Web of Science ®Google Scholar
• Mabry R, Gilbertson DG, Frank A, et al. (2010). A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo. MAbs 2:20–34.
   PubMed Web of Science ®Google Scholar
• Maria DN, Mishra SR, Wang L, et al. (2017). Water-soluble complex of curcumin with cyclodextrins: enhanced physical properties for ocular drug delivery. Curr Drug Deliv 14:875–86.
   PubMed Web of Science ®Google Scholar
• Moiseev RV, Morrison P, Steele F, et al. (2019). Penetration enhancers in ocular drug delivery. Pharmaceutics 11:321.
   PubMed Web of Science ®Google Scholar
• Montenegro L, Lai F, Offerta A, et al. (2016). From nanoemulsions to nanostructured lipid carriers: a relevant development in dermal delivery of drugs and cosmetics. J Drug Deliv Sci Technol 32:100–12.
   Web of Science ®Google Scholar
• Negi LM, Jaggi M, Talegaonkar S. (2014). Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int J Pharm 461:403–10.
   PubMed Web of Science ®Google Scholar
• Nicholas MP, Mysore N. (2021). Corneal neovascularization. Exp Eye Res 202:108363.
   PubMed Web of Science ®Google Scholar
• Patel N, Nakrani H, Raval M, et al. (2016). Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. Drug Deliv 23:3712–23.
   PubMed Web of Science ®Google Scholar
• Patel PA, Patil SC, Kalaria DR, et al. (2013). Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. Int J Pharm 446:16–23.
   PubMed Web of Science ®Google Scholar
• Pérez-Santonja JJ, Campos-Mollo E, Lledó-Riquelme M, et al. (2010). Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model. Am J Ophthalmol 150:519–28.
   PubMed Web of Science ®Google Scholar
• Robbie SJ, Lundh von Leithner P, Ju M, et al. (2013). Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease. Invest Ophthalmol Vis Sci 54:1490–500.
   PubMed Web of Science ®Google Scholar
• Roshandel D, Eslani M, Baradaran-Rafii A, et al. (2018). Current and emerging therapies for corneal neovascularization. Ocul Surf 16:398–414.
   PubMed Web of Science ®Google Scholar
• Sánchez-López E, Espina M, Doktorovova S, et al. (2017). Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye –– part II – ocular drug-loaded lipid nanoparticles. Eur J Pharm Biopharm 110:58–69.
   PubMed Web of Science ®Google Scholar
• Savić V, Ilić T, Nikolić I, et al. (2019). Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: formulation characterization and assessment of dermal delivery compared to referent ointment. Int J Pharm 569:118624.
   PubMed Web of Science ®Google Scholar
• Selvaraj BR, Sridhar SK, Kesavan BR, et al. (2020). Application of statistical tooling techniques for designing of carvedilol nanolipid transferosomes and its dermatopharmacokinetic and pharmacodynamic studies. PNT 8:452–70.
   Google Scholar
• Seo JW, Chung SH, Choi JS, et al. (2012). Inhibition of corneal neovascularization in rats by systemic administration of sorafenib. Cornea 31:907–12.
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Shaw J, Al-Kassas R. (2010). Solid lipid nanoparticles for ocular drug delivery. Drug Deliv 17:467–89.
   PubMed Web of Science ®Google Scholar
• Shahab M, , Rizwanullah M, Alshehri S, Imam S. (2020). Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: in vitro, ex vivo and toxicity assessments. Int J Biol Macromol 163:2392–404.
   PubMed Web of Science ®Google Scholar
• Sharif Z, Sharif W. (2019). Corneal neovascularization: updates on pathophysiology, investigations & management. Rom J Ophthalmol 63:15–22.
   PubMedGoogle Scholar
• Shen J, Deng Y, Jin X, et al. (2010). Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution. Int J Pharm 402:248–53.
   PubMed Web of Science ®Google Scholar
• Shi S, Peng F, Zheng Q, et al. (2019). Micelle-solubilized axitinib for ocular administration in anti-neovascularization. Int J Pharm 560:19–26.
   PubMed Web of Science ®Google Scholar
• Siedlecki J, Wertheimer C, Wolf A, et al. (2017). Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro. Graefes Arch Clin Exp Ophthalmol 255:963–72.
   PubMed Web of Science ®Google Scholar
• Thiele S, Liegl RG, König S, et al. (2013). Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety Accepted Manuscriptevaluations of axitinib, pazopanib and sorafenib for intraocular use. Klin Monbl Augenheilkd 230:247–54.
   PubMed Web of Science ®Google Scholar
• Vieira R, Severino P, Nalone LA, et al. (2020). Sucupira oil-loaded nanostructured lipid carriers (NLC): lipid screening, factorial design, release profile, and cytotoxicity. Molecules 25:685.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Huang J, et al. (2019). Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate. Int J Pharm 562:31–41.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Carter C, Lynch M, et al. (2006). Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 5:835–44.
   PubMed Web of Science ®Google Scholar
• Xiao O, Xie ZL, Lin BW, et al. (2012). Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS One 7:e41858.
   PubMed Web of Science ®Google Scholar
• Yildirim H, Aydemir O, Balbaba M, et al. (2020). Comparison of the effect of topical bevacizumab and sorafenib in experimental corneal neovascularization. Cutan Ocul Toxicol 39:223–8.
   PubMed Web of Science ®Google Scholar
• Yoon KC, Ahn KY, Lee SE, et al. (2006). Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin. Curr Eye Res 31:215–24.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xu S, Yu S, et al. (2020). A hybrid genipin-cross-linked hydrogel/nanostructured lipid carrier for ocular drug delivery: cellular, ex vivo, and in vivo evaluation. ACS Biomater Sci Eng 6:1543–52.
   PubMed Web of Science ®Google Scholar
• Zafar A, Alruwaili N, Imam S, et al. (2021). Formulation of carteolol chitosomes for ocular delivery: formulation optimization, ex-vivo permeation, and ocular toxicity examination. Cutan Ocul Toxicol 40:38–349.
   Web of Science ®Google Scholar
• Zakkula A, Gabani BB, Jairam RK, et al. (2020). Preparation and optimization of nilotinib self-micro-emulsifying drug delivery systems to enhance oral bioavailability. Drug Dev Ind Pharm 46:498–504.
   PubMed Web of Science ®Google Scholar
• Zeng F, Wang D, Tian Y, et al. (2021). Nanoemulsion for improving the oral bioavailability of hesperetin: formulation optimization and absorption mechanism. J Pharm Sci 110:2555–61.
   PubMed Web of Science ®Google Scholar
• Zhang SX, Ma JX. (2007). Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26:1–37.
   PubMed Web of Science ®Google Scholar
• Zhou T, Miao Y, Li Z, et al. (2020). A comparative ocular pharmacokinetics study of preservative-free latanoprost unit-dose eye drops and a benzalkonium chloride-preserved branded product following topical application to rabbits . J Ocul Pharmacol Ther 36:522–8.
   PubMed Web of Science ®Google Scholar
• Zhou SY, Xie ZL, Xiao O, et al. (2010). Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1. Mol Vis 16:1389–98.
   PubMed Web of Science ®Google Scholar
• Zhou T, Zhu L, Xia H, et al. (2017). Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: in vitro characterization and in vivo permeation. Eur J Pharm Sci 109:288–96.
   PubMed Web of Science ®Google Scholar
• Zhu W, Yu A, Wang W, et al. (2008). Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 360:184–90.
   PubMed Web of Science ®Google Scholar